Paydirt
AD
Insider

A. Sinclair Dunlop

Director

A. Sinclair Dunlop (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in APLS. The largest single filing was $738K of APLS (31,092 sh × $23.72, as filed), executed Oct 10 2025.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.4M
shares × price, as filed
Last traded
Oct 10 2025
Filed Oct 15 2025
Open performance→
Volume by month
$1.4M$720K$0Oct 2024Apr 2025Oct 2025Apr 2026Sep 2025 · sells $714KOct 2025 · sells $1.4M
Buys $0 Sells $2.2M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Not on file 2 filings

Sector per market data · by filing · past 12 months

Most traded names
APLS APLS APLS · 0 buys · 3 sells 3 filings
Recent filings
APLSSALE Apellis Pharmaceuticals, Inc. View filing → $738K
31,092 sh × $23.72
Exec Oct 10 2025
Filed Oct 15 2025 · 5:30 PM ET APLSSALE Apellis Pharmaceuticals, Inc. View filing → $702K
31,092 sh × $22.58
Exec Sep 30 2025
Filed Oct 2 2025 · 5:30 PM ET APLSSALE Apellis Pharmaceuticals, Inc. View filing → $714K
31,092 sh × $22.95
Exec Sep 19 2025
Filed Sep 19 2025 · 5:30 PM ET APLSSALE Apellis Pharmaceuticals, Inc. View filing → $1.3M
37,000 sh across 2 lots
Exec Sep 16 2024
Filed Sep 17 2024 · 5:30 PM ET